CAS: 1672-50-0; 4,5-Diamino-6-Hydroxypyrimidine

该化合物是属于六种含有氮原子的杂交环化合物,六种含有氮原子的杂交环化合物的有机化合物;该物质有两种氨基组(-NH2)和一种附于此环的氢氧基组(-OH),有助于其在极地溶剂中的再活性和溶解性;该物质一般是白到白的晶状固体,以其作为各种药物和农用化学合成的中间体而著称;由于存在多种功能组,它能够参与各种化学反应,包括涉及核生殖器替代和凝聚反应的化学反应;此外,4,5-dimino-6-Hyroycypypypyrimidine对生物化学研究感兴趣,特别是与核酸代谢和酶活性有关的研究;其特性使其成为医药化学和生物化学和生物化学中的宝贵化合物,但处理时应当考虑到潜在的生物活动.

结构式图片

相似化合物

1004-76-8 69785-94-0 52502-66-6

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1004-76-8 2-巯基-4-羟基-5,6-二氨基嘧啶 | CAS号36746-26-6 6-amino-5-nitro... | CAS号4316-98-7 6-氯嘧啶-4,5-二胺 | CAS号2846-89-1 4,5-二氨基-6-巯基嘧啶 | CAS号69816-38-2 2-氨基-5-三氟甲基吡嗪 | CAS号64194-58-7 6-氨基-5-甲氨基-3H-嘧啶-4-酮 | CAS号13231-00-0 7H-嘌呤-6,8-二醇 | CAS号34244-80-9 7-Methyl-4(1H)-... | CAS号7598-41-6 [1,2,5]噻二唑并[3,4... | CAS号7698-94-4 [1,2,5]Selenadi... | CAS号50609-15-9 N-(6-amino-4-ox...

合成工艺路线路线简述

    4,5-Diamino-6-Hydroxypyrimidine Sulphate置于polymer-Supported Carbonate体系中,用 N,N-二甲基甲酰胺,乙腈 用作溶剂,化学反应 24.0H,反应生成4,5-二氨基-6-羟基嘧啶
    参考文献:Wo2007/71966
    标题:Wo2007/71966

    专利信息


    专利号:US-7060818-B2
    优先权日:2003-02-21
    标题:Synthesis of macrocyclic tetraamido compounds and new metal insertion process
    发明人:HORWITZ COLIN P; GHOSH ANINDYA
    权利人:UNIV CARNEGIE MELLON
    摘要:An improved method of synthesizing a macrocyclic tetraamido compound includes protecting the amino portion of an amino carboxylic acid to form a protected amino carboxylic acid; exposing the protected amino carboxylic acid to a first solvent, preferably a hydrocarbon solvent, such as toluene or 1,2-dichloroethane, dichloromethane, dibromomethane and 1,2-dibromoethane. The carboxylic acid portion of the protected amino carboxylic acid is then converted to an activated carboxylic acid by one of esterification or acid halide formation, to form a protected amino activated carboxylic acid derivative. The protected amino activated carboxylic acid derivative is reacted with a diamine in the presence of a second solvent, such as THF or ,2-dichloroethane, dichloromethane, dibromomethane and 1,2-dibromoethane, to form a protected diamide diamine intermediate. Following deprotection, the diamide diamine intermediate is reacted with an activated diacid, such as an activated malonate, oxalate or succinate derivative to form the macrocyclic tetraamido compound. The macrocyclic tetraamido compound may further be complexed with a transition metal.

    专利号:US-6153615-A
    优先权日:1991-12-26
    标 题 :Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis
    发明人:GROSS STEVEN S
    权利人:CORNELL RES FOUNDATION INC
    摘要:Guanosine triphosphate pathway tetrahydrobiopterin synthesis antagonist and/or pterin salvage pathway tetrahydrobiopterin synthesis antagonists are administered to inhibit nitric oxide synthesis from arginine in vascular cells in a subject in need of such inhibition (e.g., for prophylactic or curative effect for endotoxin- or cytokine-induced hypotension or for restoration of vascular contractile sensitivity to pressor agents in the treatment of such hypotension). The tetrahydrobiopterin synthesis antagonist may be administered with α 1 -adrenergic agonist or with nitric oxide synthase inhibitor. The tetrahydrobiopterin synthesis antagonists are also administered to attenuate inflammation caused by induced nitric oxide production in immune cells. Unwanted counterproductive or side effects can be eliminated or ameliorated by administration additionally of levodopa with or without carbidopa and L-5-hydroxytryptophane.

    专利号:US-6274581-B1
    优先权日:1991-12-26
    标 题 :Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
    发明人:GROSS STEVEN S
    权利人:CORNELL RES FOUNDATION INC
    摘要:Guanosine triphosphate pathway tetrahydrobiopterin synthesis antagonist and/or pterin salvage pathway tetrahydrobiopterin synthesis antagonist are administered to inhibit nitric oxide synthesis from arginine in vascular smooth muscle cells in a subject in need of such inhibition (e.g. for prophylactic or curative effect for cytokine-induced hypotension or for restoration of vascular contractile sensitivity to pressor agents in the treatment of such hypotension).

    专利号:US-7888506-B2
    优先权日:2007-01-26
    标 题 :Composition, synthesis, and use of a new class of fluorophores
    发明人:BASU PARTHA; SERLI MITASEV BARBARA
    权利人:UNIV HOLY GHOST DUQUESNE
    摘要:A new class of fluorophores is presented. The fluorophores include a conjugated ring system, such as a dithiolone, a pyran, and a pyrazine containing ring system. The structure is designed with the flexibility to have multiple substitution patterns. The fluorophores may be used in applications including, but not limited to, biomarker applications, pH sensors, metal sensors, and as components for molecular electronics.

    专利号:WO-2004076425-A1
    优先权日:2003-02-21
    标题:Improved synthesis of macrocyclic tetraamido compounds and new metal insertion process

    专利号:US-5877176-A
    优先权日:1991-12-26
    标题 :Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
    上海泰锐尔生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shtrl.com
    电话: 021-54822871 13817743194👤
    📞上海泰锐尔生物科技有限公司 ⚠️参考联系方式

    销售电话:021-54822871 13817743194
    邮箱:info@shtrl.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Ishikawa, T., Science of Synthesis Knowledge Updates, (2012) 2, 307.
    摘要:Liang, Y.; Wen, Z.; Cabrera, M.; Howlader, A. H.; Wnuk, S. F., Science of Synthesis Knowledge Updates, (2020) 1, 202.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知